Aligos Therapeutics, Inc.
ALGS
$7.22
-$0.43-5.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -60.17% | 36.71% | 32.27% | 30.05% | 22.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -11.68% | -3.54% | -11.45% | -0.70% | 0.36% |
| Total Current Assets | -58.36% | 33.35% | 29.58% | 28.50% | 21.29% |
|
|
|||||
| Total Current Assets | -58.36% | 33.35% | 29.58% | 28.50% | 21.29% |
| Net Property, Plant & Equipment | -39.23% | -32.35% | -29.53% | -28.90% | -25.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 20.09% | 14.04% | 12.28% | 1.43% | 1.12% |
| Total Assets | -57.16% | 26.31% | 24.13% | 23.80% | 17.82% |
|
|
|||||
| Total Accounts Payable | 71.28% | 54.88% | 69.74% | -42.26% | 56.93% |
| Total Accrued Expenses | 8.98% | -13.06% | -3.93% | 1.20% | -8.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.94% | 7.72% | 4.79% | 5.51% | 6.51% |
| Total Finance Division Other Current Liabilities | -- | -- | -74.35% | -56.33% | -- |
| Total Other Current Liabilities | -- | -- | -74.35% | -56.33% | -- |
| Total Current Liabilities | 23.08% | -2.32% | 4.92% | -14.00% | 0.36% |
|
|
|||||
| Total Current Liabilities | 23.08% | -2.32% | 4.92% | -14.00% | 0.36% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -84.98% | -68.99% | -56.36% | -48.50% | -39.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.52% | -83.11% | 15.47% | -19.93% | -74.01% |
| Total Liabilities | -4.34% | -64.68% | -1.04% | -21.02% | -49.70% |
|
|
|||||
| Common Stock & APIC | 0.82% | 18.13% | 18.50% | 18.67% | 18.92% |
| Retained Earnings | -15.71% | -3.91% | -16.14% | -14.36% | -10.21% |
| Treasury Stock & Other | -2.01% | 3.77% | -21.14% | -14.98% | -6.09% |
| Total Common Equity | -72.70% | 284.81% | 43.39% | 51.52% | 94.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -72.70% | 284.81% | 43.39% | 51.52% | 94.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -72.70% | 284.81% | 43.39% | 51.52% | 94.74% |
|
|
|||||